András Egyed

Title: András Egyed: Innovator in Pharmaceutical Chemistry

Introduction

András Egyed is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target central nervous system disorders. With a total of 3 patents to his name, his work has implications for the treatment of various medical conditions.

Latest Patents

Egyed's latest patents include innovative compounds such as 8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, which serve as AMPA/kainate receptor inhibitors. This patent discloses a novel compound of formula I and its pharmaceutically acceptable quaternary ammonium salts. The compounds possess unique competitive AMPA/kainate antagonist properties, making them useful in treating diseases where inhibition of these receptors may have a favorable effect. Another significant patent involves piperazinylalkylthiopyrimidine derivatives, which are also aimed at treating central nervous system disorders, particularly anxiety.

Career Highlights

Throughout his career, András Egyed has worked with various companies, including Egis Gyogyszergyar Rt. His expertise in pharmaceutical chemistry has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Egyed has collaborated with notable colleagues such as Gyula Simig and Károly Tihanyi. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

András Egyed's contributions to pharmaceutical chemistry highlight his role as an innovator in the field. His patents reflect a commitment to developing effective treatments for central nervous system disorders, showcasing the importance of innovation in healthcare.